|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wu Y, Sarkissyan M and Vadgama JV:
Epithelial-mesenchymal transition and breast cancer. J Clin Med.
5:52016. View Article : Google Scholar :
|
|
4
|
Endres M, Kneitz S, Orth MF, Perera RK,
Zernecke A and Butt E: Regulation of matrix metalloproteinases
(MMPs) expression and secretion in MDA-MB-231 breast cancer cells
by LIM and SH3 protein 1 (LASP1). Oncotarget. 7:64244–64259. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human MicroRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Croce CM and Calin GA: miRNAs, cancer, and
stem cell division. Cell. 122:6–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zheng Y, Lv X, Wang X, Wang B, Shao X,
Huang Y, Shi L, Chen Z, Huang J and Huang P: MiR-181b promotes
chemoresistance in breast cancer by regulating Bim expression.
Oncol Rep. 35:683–690. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu X, Zhang Y, Jasper J, Lykken E,
Alexander PB, Markowitz GJ, McDonnell DP, Li QJ and Wang XF:
MiR-148a functions to suppress metastasis and serves as a
prognostic indicator in triple-negative breast cancer. Oncotarget.
7:20381–20394. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ji Y, Han Z, Shao L and Zhao Y: Evaluation
of in vivo antitumor effects of low-frequency ultrasound-mediated
miRNA-133a microbubble delivery in breast cancer. Cancer Med.
5:2534–2543. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen G, Fang T, Huang Z, Qi Y, Du S, Di T,
Lei Z, Zhang X and Yan W: MicroRNA-133a inhibits osteosarcoma cells
proliferation and invasion via targeting IGF-1R. Cell Physiol
Biochem. 38:598–608. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zheng K, Liu W, Liu Y, Jiang C and Qian Q:
MicroRNA-133a suppresses colorectal cancer cell invasion by
targeting Fascin1. Oncol Lett. 9:869–874. 2015.PubMed/NCBI
|
|
14
|
Wu ZS, Wang CQ, Xiang R, Liu X, Ye S, Yang
XQ, Zhang GH, Xu XC, Zhu T and Wu Q: Loss of miR-133a expression
associated with poor survival of breast cancer and restoration of
miR-133a expression inhibited breast cancer cell growth and
invasion. BMC Cancer. 12:512012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cui W, Zhang S, Shan C, Zhou L and Zhou Z:
microRNA-133a regulates the cell cycle and proliferation of breast
cancer cells by targeting epidermal growth factor receptor through
the EGFR/Akt signaling pathway. FEBS J. 280:3962–3974. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin X, Liu X, Fang Y and Weng X: LIM and
SH3 protein 1 promotes tumor proliferation and metastasis in lung
carcinoma. Oncol Lett. 12:4756–4760. 2016.PubMed/NCBI
|
|
17
|
Takeshita N, Mori M, Kano M, Hoshino I,
Akutsu Y, Hanari N, Yoneyama Y, Ikeda N, Isozaki Y, Maruyama T, et
al: miR-203 inhibits the migration and invasion of esophageal
squamous cell carcinoma by regulating LASP1. Int J Oncol.
41:1653–1661. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu Z, Cui Y, Zhou Y, Zhou K, Qiao X, Li C
and Wang S: MicroRNA-29a plays a suppressive role in non-small cell
lung cancer cells via targeting LASP1. Onco Targets Ther.
9:6999–7009. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang C, Zheng X, Shen C and Shi Y:
MicroRNA-203 suppresses cell proliferation and migration by
targeting BIRC5 and LASP1 in human triple-negative breast cancer
cells. J Exp Clin Cancer Res. 31:582012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li H, Xiang Z, Liu Y, Xu B and Tang J:
MicroRNA-133b inhibits proliferation, cellular migration, and
invasion via targeting LASP1 in hepatocarcinoma cells. Oncol Res.
25:1269–1282. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chan M, Liaw CS, Ji SM, Tan HH, Wong CY,
Thike AA, Tan PH, Ho GH and Lee AS: Identification of circulating
microRNA signatures for breast cancer detection. Clin Cancer Res.
19:4477–4487. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Orth MF, Cazes A, Butt E and Grunewald TG:
An update on the LIM and SH3 domain protein 1 (LASP1): A versatile
structural, signaling, and biomarker protein. Oncotarget. 6:26–42.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang LL, Wang L, Wang XY, Shang D, Yin SJ,
Sun LL and Ji HB: MicroRNA-218 inhibits the proliferation,
migration, and invasion and promotes apoptosis of gastric cancer
cells by targeting LASP1. Tumour Biol. 37:15241–15252. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Du YY, Zhao LM, Chen L, Sang MX, Li J, Ma
M and Liu JF: The tumor-suppressive function of miR-1 by targeting
LASP1 and TAGLN2 in esophageal squamous cell carcinoma. J
Gastroenterol Hepatol. 31:384–393. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang H, Shi J, Luo Y, Liao Q, Niu Y, Zhang
F, Shao Z, Ding Y and Zhao L: LIM and SH3 protein 1 induces
TGFβ-mediated epithelial-mesenchymal transition in human colorectal
cancer by regulating S100A4 expression. Clin Cancer Res.
20:5835–5847. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Traenka C, Remke M, Korshunov A, Bender S,
Hielscher T, Northcott PA, Witt H, Ryzhova M, Felsberg J, Benner A,
et al: Role of LIM and SH3 protein 1 (LASP1) in the metastatic
dissemination of medulloblastoma. Cancer Res. 70:8003–8014. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Frietsch JJ, Grunewald TG, Jasper S,
Kammerer U, Herterich S, Kapp M, Honig A and Butt E: Nuclear
localisation of LASP-1 correlates with poor long-term survival in
female breast cancer. Br J Cancer. 102:1645–1653. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang H, An H, Wang B, Liao Q, Li W, Jin X,
Cui S, Zhang Y, Ding Y and Zhao L: miR-133a represses tumour growth
and metastasis in colorectal cancer by targeting LIM and SH3
protein 1 and inhibiting the MAPK pathway. Eur J Cancer.
49:3924–3935. 2013. View Article : Google Scholar : PubMed/NCBI
|
